DrugsNews.net

Drugs Xagena

Xagena Mappa
Medical Meeting
Onco News
Xagena Salute

Search results for "Osimertinib"

The FDA ( Food and Drug Administration ) has granted accelerated approval for an oral medication to treat patients with advanced non-small cell lung cancer ( NSCLC ). Tagrisso ( Osimertinib ) is now ...


The FDA ( Food and Drug Administration ) has approved a new second-generation lung cancer treatment that can help many patients in their battle against the disease. Lung cancer patients got another ro ...


The FDA ( Food and Drug Administration ) has granted full approval for Tagrisso ( Osimertinib ) 80mg once-daily tablets, for the treatment of patients with metastatic epidermal growth factor receptor ...


The European Commission has granted marketing authorisation for Tagrisso ( Osimertinib ), a third-generation, irreversible EGFR-TKI, as monotherapy for the 1st-line treatment of adult patients with lo ...


The Food and Drug Administration ( FDA ) has approved Osimertinib ( Tagrisso ) for the first-line treatment of patients with metastatic non-small cell lung cancer ( NSCLC ) whose tumors have epidermal ...